京东健康发布2025年第一季度业绩,收入同比增长25.5%至166.45亿元人民币,经营盈利同比增长近两倍达10.71亿元。公司在一季度线上首发多款创新药品,包括辉瑞的泰泽纳、Esteve的利舒仁等,为患者提供更多用药选择。此外,京东健康在医疗AI领域取得多项进展,推动AI技术在医疗服务中的应用。里昂研报预计京东健康今年首季关键绩效指标表现稳健,总收入料同比升15%至153亿元人民币,主要受益于...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.